New study aims to predict liver injury outcomes in thousands of patients
NCT ID NCT05060289
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 3000 people in China who have drug-induced liver injury (DILI) to understand what factors affect their recovery. Researchers will collect blood samples and health data to create a model that predicts serious outcomes like liver failure or death. The goal is to improve how doctors manage DILI and identify patients who need closer monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a tool that helps doctors better predict who will recover or need a liver transplant after drug-induced liver injury.
What could go wrong
This is an observational study, not a treatment trial. The model may not work for all patients or be ready for use for many years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG INDUCED LIVER INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing 302 Hospital
RECRUITINGBeijing, Beijing Municipality, 100166, China
Contact
-
Beijing Ditan Hospital
ACTIVE_NOT_RECRUITINGBeijing, 100102, China
-
Beijing Friendship Hospital, Capital Medical University
RECRUITINGBeijing, 100050, China
Contact
Contact Email: •••••@•••••
-
Beijing You 'an Hospital, Capital Medical University
RECRUITINGBeijing, 100069, China
Contact
Contact
Contact
-
Hebei CNPC Central Hospital
ACTIVE_NOT_RECRUITINGHebei, 050011, China
-
Jiaozuo People's Hospital
RECRUITINGJiaozuo, 454002, China
Contact
Contact
Contact
-
Peking University Third Hospital
ACTIVE_NOT_RECRUITINGBeijing, 100191, China
-
Qinghai People's Hospital
RECRUITINGQinghai, 810007, China
Contact
Contact
-
Qinzhou First People's Hospital
ACTIVE_NOT_RECRUITINGGuangxi, 535009, China
-
The Affiliated Hospital of Qingdao University
RECRUITINGQingdao, 266003, China
Contact
-
The Second Affiliated Hospital of Dalian Medical University
RECRUITINGDalian, 116023, China
Contact
Contact
-
The Second Hospital of Lanzhou University
RECRUITINGLanzhou, 730046, China
Contact
-
Yuncheng Central Hospital
RECRUITINGYuncheng, 044099, China
Contact
Contact